ATPS-75 TARGETING THE Mdm2-Akt SIGNALING NETWORK IN COMBINATION WITH TEMOZOLOMIDE IMPROVES EFFICACY IN ECTOPIC AND ORTHOTOPIC PATIENT-DERIVED GLIOBLASTOMA XENOGRAFT MODELS

Ítems similars

• Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist
  per: Wang, Haiyan, et al.
  Publicat: (2016)
• TRTH-14. TARGETING CHK1 AND AKT CROSSTALK IN MUTANT P53 PEDIATRIC GLIOBLASTOMA
  per: Stamatkin, Chris, et al.
  Publicat: (2017)
• ATPS-21 MONITORING OF LOCAL TREATMENT EFFECTS WITH TEMOZOLOMIDE IN AN ORTHOTOPIC MURINE GLIOBLASTOMA MODEL
  per: Faymonville, Andrea, et al.
  Publicat: (2015)
• Combining Bevacizumab with Temozolomide Increases the Antitumor Efficacy of Temozolomide in a Human Glioblastoma Orthotopic Xenograft Model
  per: Mathieu, Véronique, et al.
  Publicat: (2008)
• The Role of MDM2 in Promoting Genome Stability versus Instability
  per: Saadatzadeh, M. Reza, et al.
  Publicat: (2017)